ICMR to Commercialise Indigenous Malaria Vaccine
The Indian Council of Medical Research (ICMR) has taken a major step in public health innovation by initiating the process to commercialise a recombinant multi-stage malaria vaccine, AdFalciVax. ICMR has released an Expression of Interest (EoI) inviting pharmaceutical companies and manufacturers to collaborate in transferring the technology and mass-producing the vaccine, aiming to tackle Plasmodium falciparum, the most deadly malaria parasite in humans.
India reports a large burden of malaria cases, especially from Plasmodium falciparum in tribal and underdeveloped regions. An indigenously developed vaccine can improve accessibility, affordability, and reduce dependence on global vaccine suppliers. It also aligns with India’s public health goal to eliminate malaria by 2030.
India has been successfully re-elected to the Council of the International Telecommunication Union (ITU) for…
Former India & Chennai Super Kings captain Mahendra Singh Dhoni has retired from the Indian…
The Mekedatu Dam Project is a proposal for building a balancing reservoir and drinking water…
Doctors at the All India Institute of Medical Sciences (AIIMS) in New Delhi have completed…
The Reserve Bank of India has cancelled Certificates of Registration (CoRs) of 49 NBFCs and…
Trust in Times of Crisis: The Story of a Citizens’ Relief Effort for the Pandemic…